Like every recent health-care overhaul attempt, including Obamacare, the latest GOP effort fails to address one major systemic problem. » Read More
By: Dan Mangan
The hearing comes five days before the deadline for passing an Obamacare replacement bill under special rules the GOP is using. » Read More
Republicans' health care bill will cost Alaska Medicaid recipients about $3 billion, Vox reports.
Americans don't like the way President Donald Trump is going about changing the health-care system, a poll says.
Eight to 10 Republican U.S. senators have serious concerns about Republican health-care legislation to roll back Obamacare, said Republican Senator Susan Collins.
The dollar has tumbled, but analysts weren’t pointing to weaker-than-expected U.S. inflation. Instead, they fingered a “Trump discount."
Unicorns are mythical for a reason.
Martin Shkreli "doesn't seem to see other people as important if they don't fit into the scheme of what he wants," said Retrophin's CEO.
Some Medicare beneficiaries are being prescribed opioids by 10 or more doctors, Propublica reports.
Medicare generally doesn't cover those costs of home-based care or nursing homes, N.Y. Times reports.
A few politicians wanted to spend more money and they got what they wanted, Grover Norquist says.
The revised Senate bill turns Obamacare into a high-risk pool, says Vox's Ezra Klein.
The latest Senate health-care bill is dredging up an old question: What constitutes the freedom to choose in the health insurance market?
On health care reform. Republicans are looking for at least 50 votes to pass Obamacare overhaul, Vox reports.
GOP health bill offers little protection for the insured who actually get sick, says Jennifer Fitzgerald.
Mulvaney also defends the Trump administration's position that getting rid of Obamacare will have a positive impact on GDP.
Senate Republican leaders released on Thursday a revised plan that drew criticism from senators on both sides of the political divide within the Republican party.
The U.S. has a greater divide between health care between the rich and the poor than 10 other countries, according to a new Commonwealth Fund study.
Jim Cramer explains why the tides may not be turning for retail just yet.
Jim Cramer admits he was too eager about the stock of Alder BioPharmaceuticals, which just took a huge hit.
Steven Aselage testified that Shkreli was "a unique talent" who at times was "not as credible as he could have been."
Get the best of CNBC in your inbox